Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 36 of Coherus Oncology, Inc.'s SEC filings and found 1 warrant series, 1 convertible, 2 ATM programs, 2 shelf registrations and 2 completed offerings on file for CHRS. The latest dilution event on file is ATM sales on Aug 28, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
SPRBSpruce Biosciences, Inc.
FHTXFoghorn Therapeutics Inc.
NBPNovaBridge Biosciences
HUMAHumacyte, Inc.
CDXSCodexis, Inc.
MOLNMolecular Partners AG American Depositary Shares
NERVMinerva Neurosciences, Inc.
NMRANeumora Therapeutics, Inc. Common Stock
LENZLENZ Therapeutics, Inc.
PYPDPolyPid Ltd. Ordinary Shares
MENSJyong Biotech Ltd. Ordinary Shares
HURATuHURA Biosciences, Inc.
AVXLAnavex Life Sciences Corp.
MSLESatellos Bioscience Inc.
CMPXCompass Therapeutics, Inc.